Public Employees Retirement System of Ohio Has $3.21 Million Stake in Enovis Co. (NYSE:ENOV)

Public Employees Retirement System of Ohio reduced its holdings in Enovis Co. (NYSE:ENOV) by 1.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 74,471 shares of the company’s stock after selling 878 shares during the period. Public Employees Retirement System of Ohio owned 0.13% of Enovis worth $3,206,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Envestnet Portfolio Solutions Inc. increased its position in shares of Enovis by 44.0% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 9,033 shares of the company’s stock worth $408,000 after purchasing an additional 2,761 shares during the last quarter. Tributary Capital Management LLC grew its stake in shares of Enovis by 20.9% in the second quarter. Tributary Capital Management LLC now owns 409,190 shares of the company’s stock valued at $18,495,000 after buying an additional 70,819 shares in the last quarter. Institute for Wealth Management LLC. acquired a new position in Enovis during the second quarter worth $241,000. AMG National Trust Bank raised its position in Enovis by 70.4% during the second quarter. AMG National Trust Bank now owns 27,808 shares of the company’s stock worth $1,257,000 after acquiring an additional 11,486 shares in the last quarter. Finally, AlphaCentric Advisors LLC bought a new stake in Enovis during the second quarter worth $904,000. 98.45% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research analysts have recently weighed in on the stock. Needham & Company LLC restated a “buy” rating and set a $65.00 price objective on shares of Enovis in a research note on Thursday, November 7th. JMP Securities started coverage on Enovis in a research report on Thursday, October 3rd. They set an “outperform” rating and a $62.00 price target on the stock. Finally, Evercore ISI dropped their price objective on Enovis from $62.00 to $58.00 and set an “outperform” rating on the stock in a research note on Tuesday, October 1st. One equities research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $67.00.

Enovis Price Performance

Shares of NYSE ENOV opened at $45.78 on Tuesday. The business’s 50 day moving average is $44.38 and its 200-day moving average is $44.56. The firm has a market cap of $2.56 billion, a P/E ratio of -20.90 and a beta of 1.94. Enovis Co. has a 1-year low of $38.27 and a 1-year high of $65.03. The company has a current ratio of 2.27, a quick ratio of 1.12 and a debt-to-equity ratio of 0.40.

Enovis (NYSE:ENOV) last posted its earnings results on Wednesday, November 6th. The company reported $0.73 earnings per share for the quarter, topping analysts’ consensus estimates of $0.62 by $0.11. Enovis had a positive return on equity of 4.39% and a negative net margin of 5.95%. The company had revenue of $505.22 million during the quarter, compared to the consensus estimate of $504.44 million. During the same quarter last year, the firm earned $0.56 earnings per share. The company’s revenue was up 21.0% on a year-over-year basis. Equities research analysts predict that Enovis Co. will post 2.79 earnings per share for the current year.

Enovis Company Profile

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments.